Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • AUGUST 2020 Issue has been successfully launched on 1 August 2020.



Jeswin Mariam Zacharia*, Ashly Justin, Minu Mariam Jose, Dr. Mathew George, Dr. Sheetal S. and Dr. Santhosh M. Mathews


Pain is one of the most common reason for seeking medical attention. Neuropathic pain is among the most common type of pain. Despite its prevalence neuropathic pain is often unrecognised and inadequately treated. This prospective observational study was conducted in 80 patients and was designed to evaluate the effect of Gabapentin and Flupirtine in neuropathic pain. As there are only few studies in the Indian literature regarding the flupirtine efficacy in neuropathic pain, the present study is undertaken. The effectiveness of the drugs under study was assessed by using Short Form McGill Pain Questionnaire and Visual Analogue Scale. Quality of life was determined by using EuroQol-5Dimension Health Questionnaire and sleep quality was assessed using Pittsburgh Sleep Quality Index. Medication adherence of the patients were determined by means of Morisky 8-Item Medication Adherence Scale and the safety of drugs were assessed by means of Naranjo Causality Assessment Scale. Gabapentin group showed reduced Short Form McGill Pain Questionnaire and Visual Analogue Scale pain scores compared to the flupirtine group. 90% of patients receiving gabapentin therapy showed no adverse drug reactions whereas 95% patients receiving flupirtine therapy showed no adverse drug reactions. Both drugs show statistical significance in quality of life with respect to mobility, self care, usual activities, pain and anxiety. On comparing both groups in terms of quality of life, patients under gabapentin therapy showed much more improvement, as gabapentin therapy showed a greater reduction in pain intensity. The study demonstrate that Gabapentin was more statistically significant in effectiveness compared with flupirtine. Both drugs are found to be safe on evaluation of various adverse drug reactions.

Keywords: Flupirtine, Gabapentin, Neuropathic pain.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More